Publication | Closed Access

The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer

Surgical OncologyUrologyGenitourinary CancerConformal Treatment PlanningMedicineNeoadjuvant Hormonal TherapyBrachytherapyProstatic DiseaseComparative PlanningOncologyRadiation Oncology